Position in ABBV
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$1,244,107
+$257,139 QoQ
Shares Held
4,944
+8.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.40%
of 13F equity value
Holder Rank
#2,343
of 4,153 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Winthrop Advisory Group LLC holds $8,653,027 across 8 Drug Manufacturers - General names. ABBV ranks #3 (14.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
10,894 | $2,766,749 | |
| 2 | LLY |
ELI LILLY & Co
|
1,928 | $2,312,500 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
4,944 | $1,244,107 | |
| 4 | MRK |
Merck & Co., Inc.
|
7,931 | $1,019,133 | |
| 5 | AMGN |
Amgen Inc
|
1,052 | $380,949 | |
| 6 | PFE |
Pfizer Inc
|
14,384 | $346,365 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
2,429 | $306,879 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
4,796 | $276,345 |
All Filings in ABBV
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,244,107 | 4,944 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $986,968 | 4,538 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $1,078,700 | 4,721 | Shares | Other | 2026-01-21 | |
| 2025-09-30 | $1,034,057 | 4,466 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $845,499 | 4,555 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $650,559 | 3,105 | Shares | Sole | 2025-04-08 | |
| 2024-12-31 | $798,583 | 4,494 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $660,570 | 3,345 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $585,226 | 3,412 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $652,282 | 3,582 | Shares | Sole | 2024-04-17 | |
| 2023-12-31 | $543,014 | 3,504 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $530,951 | 3,562 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $463,201 | 3,438 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $543,770 | 3,412 | Shares | Sole | 2023-08-01 | |
| 2022-12-31 | $549,958 | 3,403 | Shares | Sole | 2023-08-03 | |
| 2022-09-30 | $596,429 | 4,444 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $680,489 | 4,443 | Shares | Sole | 2022-07-21 | |
| 2022-03-31 | $720,092 | 4,442 | Shares | Sole | 2022-04-13 | |
| 2021-12-31 | $533,476 | 3,940 | Shares | Sole | 2022-01-12 | |
| 2021-09-30 | $423,821 | 3,929 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $239,360 | 2,125 | Shares | Sole | 2021-07-14 | |
| 2021-03-31 | $231,915 | 2,143 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $227,908 | 2,127 | Shares | Sole | 2021-01-25 | |
| No filing history on record for this holder in this stock. | ||||||